LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
LENSAR, Inc.NASDAQ: LNSR
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA turns positive
Q1 FY2026 EBITDA was $37.47M, compared with -$26.27M a year earlier. Trailing-twelve-month EBITDA was $33.96M.
Context
- EBITDA amounted to 51.0% of revenue in FY2025, up 45.3 pp from a year earlier.
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $2.26M (+107.6%) for the fiscal year ending Dec 2026, a step up from the -890.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $37.47M+13291.9% QoQ
- Last fiscal yearDec 2025
- -$29.78M-890.9% YoY
- LTMMar 2026
- $33.96M+165.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +242.6% | -40.5% | -283.1 pp |
| 1 year | -890.9% | +107.6% | +998.6 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (29.78M) USD
- Year-over-year change
- -890.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (29.78M) | -890.9% |
| FY2024 | 2024-12-31 | (3.01M) | +72.4% |
| FY2023 | 2023-12-31 | (10.87M) | +34.2% |
| FY2022 | 2022-12-31 | (16.51M) | +2.0% |
| FY2021 | 2021-12-31 | (16.84M) | — |
EBITDA vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 EBITDA of $33.96M is the highest of the 10 companies compared; the peer median is -$43.26M.
- Its year-over-year change of +165.0% is the highest of 10, against a peer median of -8.6%.
- EBITDA amounts to 58.8% of revenue for LNSR, versus a peer median of 119.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $33.96M | +165.0% | — | 58.8% | |
| LTM Mar 2026 | -$4.63M | -1312.8% | — | 4.0% | |
| LTM Mar 2026 | -$20.95M | +5.5% | — | 46.7% | |
| LTM Mar 2026 | -$34.64M | +5.7% | — | 107.3% | |
| LTM Mar 2026 | -$37.85M | +9.1% | — | 200.6% | |
| LTM Mar 2026 | -$43.26M | -365.8% | — | 40.4% | |
| LTM Mar 2026 | -$43.73M | +9.5% | — | 8329.5% | |
| LTM Mar 2026 | -$45.12M | -8.6% | — | 131.2% | |
| LTM Mar 2026 | -$84.28M | -67.4% | — | — | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | -$92.94M | -14.3% | — | 5021.0% |
| Peer median (excluding LNSR) | -$43.26M | -8.6% | — | 119.3% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.46M | 35.36M | 42.16M | 53.49M | 58.44M |
| Cost of Revenue | 16.63M | 15.4M | 21.06M | 27.64M | 31.31M |
| Gross Profit | 17.83M | 19.96M | 21.11M | 25.85M | 27.12M |
| Gross Margin | 51.8% | 56.4% | 50.1% | 48.3% | 46.4% |
| Research & Development | 12.36M | 11.81M | 6.14M | 5.33M | 5.62M |
| Selling, General & Admin | 23.89M | 27.17M | 26.1M | 26.49M | 45.16M |
| Operating Expenses | 37.49M | 40.13M | 33.34M | 36.52M | 51.7M |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| EBITDA | (16.84M) | (16.51M) | (10.87M) | (3.01M) | (29.78M) |
| EBITDA Margin | -48.9% | -46.7% | -25.8% | -5.6% | -51.0% |
| Operating Income | (19.65M) | (20.18M) | (12.23M) | (10.67M) | (24.58M) |
| Operating Margin | -57.0% | -57.1% | -29.0% | -19.9% | -42.1% |
| Interest Income | 34K | 17K | 85K | 103K | 91K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 51K | 263K | (2.15M) | (20.74M) | (9.7M) |
| Income Before Tax | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Pre-Tax Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Net Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| EPS (Basic) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| EPS (Diluted) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| Weighted Avg Shares | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
| Weighted Avg Shares (Diluted) | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.